Correction: PREX2 contributes to radiation resistance by inhibiting radiotherapy-induced tumor immunogenicity via cGAS/STING/IFNs pathway in colorectal cancer
Mingzhou Li, Jianbiao Xiao, Shasha Song, Fangyi Han, Hongling Liu, Yang Lin, Yunfei Ni, Sisi Zeng, Xin Zou, Jieqiong Wu, Feifei Wang, Shaowan Xu, You Liang, Peishuang Xu, Huirong Hong, Junfeng Qiu, Jianing Cao, Qin Zhu, Li Liang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
Topicsinterferon and immune responses · Cancer Mechanisms and Therapy · Ferroptosis and cancer prognosis
Correction: BMC Medicine 22, 154 (2024)
https://doi.org/10.1186/s12916-024–03375-2
The authors of the original article wish to clarify an error affecting Fig. 5G (the WB bands for IRF3).
The authors accidentally misplaced the image derived from Fig. 5F (the WB band of P-IRF3 in the SW480 group for the first three lanes), during the last typesetting process resulting in an inadvertent duplication of the image of the WB bands for P-IRF3 in SW480 group.
The authors have thoroughly reviewed their experimental data and image sources to identify the correct WB images, and the corrected Fig. 5 which now accurately represents the WB results for RKO can be viewed ahead in this correction article.
Fig. 5PREX2 deficiency promotes cytosolic dsDNA accumulation to activate STING signalling